CN1678324A - 雌激素替代治疗方案 - Google Patents

雌激素替代治疗方案 Download PDF

Info

Publication number
CN1678324A
CN1678324A CNA038205157A CN03820515A CN1678324A CN 1678324 A CN1678324 A CN 1678324A CN A038205157 A CNA038205157 A CN A038205157A CN 03820515 A CN03820515 A CN 03820515A CN 1678324 A CN1678324 A CN 1678324A
Authority
CN
China
Prior art keywords
estrogen
dose
daily unit
phases
daily
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA038205157A
Other languages
English (en)
Chinese (zh)
Inventor
罗伯特·卡斯珀
吉迪恩·科佩尔尼克
泽夫·肖汉姆
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CN1678324A publication Critical patent/CN1678324A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CNA038205157A 2002-08-28 2003-08-28 雌激素替代治疗方案 Pending CN1678324A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40633102P 2002-08-28 2002-08-28
US60/406,331 2002-08-28

Publications (1)

Publication Number Publication Date
CN1678324A true CN1678324A (zh) 2005-10-05

Family

ID=31978284

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA038205157A Pending CN1678324A (zh) 2002-08-28 2003-08-28 雌激素替代治疗方案

Country Status (25)

Country Link
US (1) US8946198B2 (enExample)
EP (1) EP1539184B1 (enExample)
JP (1) JP2005538150A (enExample)
KR (1) KR20050059092A (enExample)
CN (1) CN1678324A (enExample)
AT (1) ATE345804T1 (enExample)
AU (1) AU2003264203A1 (enExample)
BR (1) BR0313921A (enExample)
CA (1) CA2495330A1 (enExample)
CY (1) CY1106019T1 (enExample)
DE (1) DE60309895T2 (enExample)
DK (1) DK1539184T3 (enExample)
ES (1) ES2277139T3 (enExample)
HR (1) HRP20050291A2 (enExample)
IL (1) IL166585A0 (enExample)
MX (1) MXPA05002294A (enExample)
NO (1) NO20051545L (enExample)
NZ (1) NZ538342A (enExample)
PL (1) PL374762A1 (enExample)
PT (1) PT1539184E (enExample)
RS (1) RS20050184A (enExample)
RU (1) RU2340345C2 (enExample)
UA (1) UA82851C2 (enExample)
WO (1) WO2004019954A1 (enExample)
ZA (1) ZA200501274B (enExample)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8617597B2 (en) 2006-07-06 2013-12-31 Bayer Intellectual Property Gmbh Pharmaceutical composition containing a tetrahydrofolic acid
DE102009007771B4 (de) 2009-02-05 2012-02-16 Bayer Schering Pharma Aktiengesellschaft Bukkales Applikationssystem, 17α-Estradiol enthaltend
EP2383279A1 (en) 2011-07-19 2011-11-02 Pantarhei Bioscience B.V. Process for the preparation of estetrol
US8951996B2 (en) 2011-07-28 2015-02-10 Lipocine Inc. 17-hydroxyprogesterone ester-containing oral compositions and related methods
BR112014012444B1 (pt) 2011-11-23 2021-12-14 Therapeuticsmd, Inc Composição farmacêutica compreendendo estradiol solubilizado, progesterona e um agente de solubilização, bem como usos desta para tratar um sintoma relacionado à menopausa em uma mulher
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
AU2015229421B2 (en) * 2014-03-12 2020-06-04 Allergan Therapeutics LLC Low-dose estradiol cream
RU2016143081A (ru) 2014-05-22 2018-06-26 Терапьютиксмд, Инк. Натуральные комбинированные гормонозаместительные составы и терапии
JP6866561B2 (ja) 2015-06-18 2021-04-28 エステトラ ソシエテ プリーヴ ア レスポンサビリテ リミテ エステトロールを含有する口腔内崩壊錠
HRP20200850T1 (hr) 2015-06-18 2020-10-02 Estetra Sprl Orodisperzibilna jedinica za doziranje koja sadrži komponentu estetrola
EP3106148B1 (en) 2015-06-18 2018-03-14 Mithra Pharmaceuticals S.A. Orodispersible dosage unit containing an estetrol component
HUE054551T2 (hu) 2015-06-18 2021-09-28 Estetra Sprl Ösztetrolt tartalmazó, szájban diszpergálódó tabletta
MX2017016823A (es) 2015-06-22 2018-03-12 Lipocine Inc Composiciones orales que contienen éster de 17- hydroxiprogesterona y métodos relacionados.
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
KR20180126582A (ko) 2016-04-01 2018-11-27 쎄러퓨틱스엠디, 인코퍼레이티드 스테로이드 호르몬 약제학적 조성물
WO2017173044A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd Inc. Steroid hormone compositions in medium chain oils
KR102712911B1 (ko) 2016-08-05 2024-10-04 에스테트라, 소시에떼 아 레스폰서빌리떼 리미떼 월경통 및 생리통의 관리방법
JOP20200260A1 (ar) 2018-04-19 2019-10-19 Estetra Sprl مركبات واستخداماتها للتخفيف من الأعراض المصاحبة لانقطاع الطمث
TWI801561B (zh) 2018-04-19 2023-05-11 比利時商依思特拉私人有限責任公司 化合物及其用於緩解絕經相關症狀的用途
TWI893101B (zh) 2020-04-16 2025-08-11 比利時商埃斯特拉有限責任公司 具有降低之副作用之避孕組成物

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4826831A (en) * 1983-08-05 1989-05-02 Pre Jay Holdings Limited Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens
ATE86484T1 (de) 1987-08-08 1993-03-15 Akzo Nv Kontrazeptives implantat.
US4900734A (en) * 1987-08-27 1990-02-13 Maxson Wayne S Novel pharmaceutical composition containing estradiol and progesterone for oral administration
US5256421A (en) 1987-09-24 1993-10-26 Jencap Research Ltd. Hormone preparation and method
US5276022A (en) 1987-09-24 1994-01-04 Jencap Research Ltd. Hormone preparation and method
FI101601B1 (fi) * 1987-09-24 1998-07-31 Jencap Research Ltd Ehkäisyvalmiste sekä estrogeenin ja progestiinin käyttö ehkäisyvalmisteen valmistusmenetelmässä
US5108995A (en) 1987-09-24 1992-04-28 Jencap Research Ltd. Hormone preparation and method
US5422119A (en) 1987-09-24 1995-06-06 Jencap Research Ltd. Transdermal hormone replacement therapy
US5382873A (en) 1991-12-04 1995-01-17 U.S. Philips Corporation High-pressure discharge lamp with incandescing metal droplets
US5521166A (en) * 1994-12-19 1996-05-28 Ortho Pharmaceitical Corporation Antiprogestin cyclophasic hormonal regimen
DE19513662A1 (de) * 1995-04-08 1996-10-10 Schering Ag Pharmazeutisches Kombinationspräparat zur hormonalen Kontrazeption
HU228434B1 (en) * 1995-06-07 2013-03-28 Ortho Mcneil Pharm Inc Transdermal medicament for administering 17-deacetyl norgestimate alone or in combination with an estrogen
US6506390B2 (en) * 1996-06-25 2003-01-14 Akzo Nobel Progestogen-anti-progestogen regimens
CA2267743C (en) * 1999-03-30 2011-07-26 Robert F. Casper Low dose estrogen interrupted hormone replacement therapy
US6653298B2 (en) * 2000-01-14 2003-11-25 Sterix Limited Composition
DE10100911A1 (de) * 2001-01-11 2002-08-01 Schering Ag Verfahren zur Hormonersatztherapie und dessen Darreichungsform

Also Published As

Publication number Publication date
MXPA05002294A (es) 2005-09-12
NZ538342A (en) 2007-08-31
US8946198B2 (en) 2015-02-03
DE60309895T2 (de) 2007-10-18
ES2277139T3 (es) 2007-07-01
US20060089337A1 (en) 2006-04-27
DK1539184T3 (da) 2007-03-19
BR0313921A (pt) 2005-07-19
JP2005538150A (ja) 2005-12-15
IL166585A0 (en) 2006-01-15
EP1539184A1 (en) 2005-06-15
DE60309895D1 (de) 2007-01-04
RU2340345C2 (ru) 2008-12-10
PT1539184E (pt) 2007-02-28
HRP20050291A2 (en) 2005-10-31
CA2495330A1 (en) 2004-03-11
PL374762A1 (en) 2005-10-31
EP1539184B1 (en) 2006-11-22
CY1106019T1 (el) 2011-04-06
WO2004019954A1 (en) 2004-03-11
NO20051545L (no) 2005-03-23
KR20050059092A (ko) 2005-06-17
UA82851C2 (en) 2008-05-26
RS20050184A (sr) 2007-11-15
RU2005108977A (ru) 2005-10-10
ATE345804T1 (de) 2006-12-15
AU2003264203A1 (en) 2004-03-19
ZA200501274B (en) 2006-08-30

Similar Documents

Publication Publication Date Title
CN1678324A (zh) 雌激素替代治疗方案
JP5184727B2 (ja) 女性への非経口アンドロゲンステロイドの投与
CN1200747C (zh) 低剂量雌激素间断激素补偿治疗
CN1042296C (zh) 避孕用途的药物制剂的制备方法
JP5128743B2 (ja) ホルモン置換療法用のドロスピレノン
US5382573A (en) Hormone preparation and method
US5108995A (en) Hormone preparation and method
US5256421A (en) Hormone preparation and method
JPH10513152A (ja) 抗黄体ホルモンおよびプロゲスチンを含有する周期相ホルモン養生法
JP2005514345A (ja) 更年期以降の女性生殖機能障害の治療のための組成物
JPH08510993A (ja) ホルモン補充方法
ZA200100743B (en) Use of biogenic estrogen sulfamates for hormone replacement therapy.
WO2003084546A1 (en) Method of hormonal therapy
HK1084018A (en) Estrogen replacement regimen
Battipaglia et al. The hormonal contraceptive choice in women with polycystic ovary syndrome and metabolic syndrome
BR102024026566A2 (pt) Sistema de entrega de fármacos para combinações de estrogênio em dose ultrabaixa e métodos e usos deste
CA1332228C (en) Formulation and method for estrogen replacement therapy
DK174181B1 (da) Farmaceutisk præparat til hormonbehandling
IE84449B1 (en) Contraceptive packages containing oestrogen and progestin
TW200306197A (en) Medicament for treating climacteric post-menopausal complaints

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1084018

Country of ref document: HK

C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication
REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1084018

Country of ref document: HK